×

GLP-1 analog fusion proteins

  • US 8,273,854 B2
  • Filed: 10/31/2008
  • Issued: 09/25/2012
  • Est. Priority Date: 06/12/2003
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a patient with non-insulin dependent diabetes mellitus comprising administering to the patient a therapeutically effective amount of a heterologous fusion protein comprising:

  • a GLP-1 analog comprising SEQ ID NO;

    1

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×